BioBeats evolves from stress app to measurer of well-being
BioBeats makes apps that apply artificial intelligence in the cloud, looking for what CEO David Plans called "instances of well-being."
BioBeats stress assessment app is just one part of digital health’s stress subsector
An upcoming randomized controlled trial of BioBeats' stress assessment app will have around 700 corporate users and the trial will follow a cluster randomised controlled trial design, according to co-founder Dr David Plans.
The Power of One: Redefining Healthcare with an AI-Driven Unified Platform
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
BioBeats raises $2.28M to roll out stress analysis app to consumer, employer wellness markets
White Cloud Capital led the fundraise, and AXA Strategic Ventures and IQ Capital, also took part in the round.